SCHEMBL3934528

SCHEMBL3934528

C#CCCCC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3920827 0.92
SCHEMBL6258389 0.89 USP2 (0.58)
SCHEMBL5857720 0.89
SCHEMBL7286061 0.89 USP2 (0.58)
SCHEMBL5855797 0.89 USP2 (0.58)
SCHEMBL11471274 0.89 USP2 (0.58)
Hydrochloric Acid SCHEMBL10700534 0.87 USP2 (0.51)
Hydrochloric Acid SCHEMBL10700530 0.87 USP2 (0.51)
SCHEMBL10804039 0.83 TSHR (0.64)
SCHEMBL552086 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025217099-A1 INHIBITORS FOR HYDROGEN EMBRITTLEMENT AND METHODS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO claimed
WO-2009005839-A2 COMPOUNDS AND METHODS OF USE THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICE (US) 2009-01-08 WO claimed
WO-2025217099-A1 INHIBITORS FOR HYDROGEN EMBRITTLEMENT AND METHODS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO disclosed
WO-2025217091-A1 ODORANTS FOR FLUIDS, ODORIZED FLUIDS, METHODS, AND SYSTEMS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO disclosed
CN-109071568-A The preparation of difluoro chelating borate 国轩高科美国研究院 2018-12-21 CN disclosed
US-20170158718-A9 TITANIUM (IV) COMPOUNDS AND METHODS OF FORMING HETEROCYCLIC COMPOUNDS USING SAME REGENTS OF THE UNIVERSITY OF MINNESOTA 2017-06-08 US disclosed
WO-2009005839-A2 COMPOUNDS AND METHODS OF USE THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICE (US) 2009-01-08 WO disclosed
US-7226946-B2 Substituted phenol compounds useful for anesthesia and sedation THERAVANCE, INC. (US) 2007-06-05 US disclosed
US-7144906-B2 Heterocyclic compounds NIPPON SHINYAKU CO., LTD. (JP) 2006-12-05 US disclosed
EP-0837052-B1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO (JP) 2006-08-23 EP disclosed
US-7030143-B2 Heterocyclic compounds NIPPON SHINYAKU CO., LTD. (JP) 2006-04-18 US disclosed
EP-0837052-A1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 1998-04-22 EP disclosed
EP-0570594-B1 HYDROXAMIC ACID DERIVATIVE BASED ON AROMATIC SULFONAMIDE SHIONOGI & CO (JP) 1997-07-30 EP disclosed
US-5534654-A ANTITUMOR, ANTIINFLAMMATORY, INHIBITOR OF LYMPHOCYTE ADHESIVE FACTORS SHIONOGI & CO., LTD. (JP) 1996-07-09 US disclosed
EP-0570594-A1 HYDROXAMIC ACID DERIVATIVE BASED ON AROMATIC SULFONAMIDE SHIONOGI & CO., LTD. (JP) 1993-11-24 EP disclosed
US-5039674-A Calcium antagonistics YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-08-13 US disclosed
US-4782160-A CALCIUM RECEPTOR ANTAGONISTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1988-11-01 US disclosed
EP-0276552-A1 1,4-dihydropyridine derivatives and their production YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1988-08-03 EP disclosed
EP-0044835-A1 CATALYSED ALTERNATING COPOLYMERISATION AND PRODUCT NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1982-02-03 EP disclosed
WO-1981001289-A1 CATALYSED ALTERNATING COPOLYMERISATION AND PRODUCT BAMFORD C 1981-05-14 WO disclosed